FDA Cancels Meeting With Vaccine Experts, Raising Manufacturing Concerns
Huff PostLOADING ERROR LOADING The U.S. Food and Drug Administration has canceled an upcoming meeting with an independent advisory committee that offers recommendations on vaccine formulas, raising concerns among some of its members about potential harms to vaccine manufacturing. “The FDA will make public its recommendations to manufacturers in time for updated vaccines to be available for the 2025-2026 influenza season,” a spokesperson told HuffPost in an email Thursday. Fellow member Dr. Anna Durbin of the Johns Hopkins Bloomberg School of Public Health also expressed concern about potential harms this may cause to vaccine manufacturing. “It is not clear who made the decision to cancel the meeting or why the meeting was cancelled.” Selecting strains for the flu vaccine is usually performed in February or March using data from the World Health Organization, which the Trump administration severed ties with last month. The meeting’s cancellation follows President Donald Trump’s appointment of prominent vaccine skeptic Robert F. Kennedy Jr. as secretary of the Department of Health and Human Services, which oversees the FDA.
History of this topic
After canceling meeting of independent advisers, FDA issues 2025-26 flu vaccine recommendations
CNN
Disrupted US vaccine meetings could threaten timelines, access and transparency around shots
CNN
Disrupted US vaccine meetings could threaten timelines, access and transparency around shots
CNN
Trump administration cancels FDA vaccine advisory meeting amid flu season concerns
Hindustan Times
FDA meeting to choose flu vaccine composition canceled without explanation
CNN
Expect a bumpy ride this week when FDA advisers consider Covid-19 booster shots
CNN
Vaccine Mandates Start Rolling Out After FDA Gives Pfizer Shot Full Approval
Huff Post
US Coronavirus: FDA won’t ‘cut corners’ to approve a Covid-19 vaccine, commissioner says
CNNDiscover Related